(Total Views: 645)
Posted On: 11/17/2025 3:45:23 PM
Post# of 158778
I agree DFW,
Price is up almost 17% and volume of close to 6 million shares today has ecclipped everything in the last six months going back to the time of increased price and volume with the OSMO conference in Berlin in early May. As you point out, there has been steady, consistent, and supportive news, and the future looks bright for proactively demonstrating the cold to hot tumor activity of leronlimab and a whole new paradigm in solid tumor oncology. I hope the volume and price continue up for the next week. We are due.
Price is up almost 17% and volume of close to 6 million shares today has ecclipped everything in the last six months going back to the time of increased price and volume with the OSMO conference in Berlin in early May. As you point out, there has been steady, consistent, and supportive news, and the future looks bright for proactively demonstrating the cold to hot tumor activity of leronlimab and a whole new paradigm in solid tumor oncology. I hope the volume and price continue up for the next week. We are due.
(14)
(0)
